Boule Diagnostics AB (OSTO:BOUL) 3-Year Revenue Growth Rate : 1.20% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Boule Diagnostics AB 3-Year Revenue Growth Rate?

Boule Diagnostics AB's Revenue per Share for the three months ended in Mar. 2024 was kr3.77.

During the past 12 months, Boule Diagnostics AB's average Revenue per Share Growth Rate was -16.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Boule Diagnostics AB was 11.80% per year. The lowest was -3.90% per year. And the median was 4.90% per year.

Competitive Comparison of Boule Diagnostics AB's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Boule Diagnostics AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boule Diagnostics AB's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's 3-Year Revenue Growth Rate falls into.

Boule Diagnostics AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Boule Diagnostics AB (OSTO:BOUL) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Boule Diagnostics AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Boule Diagnostics AB (OSTO:BOUL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (OSTO:BOUL) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Domnarvsgatan 4, Spanga, SWE, SE-163 53

Website

https://www.boule.com

Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB (OSTO:BOUL) Headlines

No Headlines